Physician profile
Bruce Alan Adye
NPI 1518966480
$1,531.59
in general payments reported to CMS, 2019-2025
23 companies · $27.09 in 2025
The $27.09 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $124 · 2021: $800 · 2022: $420 · 2023: $31.76 · 2025: $27.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $58.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $58.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $410.52 | 2019-2021 | |
| Abbvie INC. | $153.44 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $131.07 | 2021-2022 | |
| Boston Scientific Corporation | $78.81 | 2022 | |
| Depuy Synthes Sales INC. | $78.18 | 2021-2022 | |
| Innocoll Pharmaceuticals Limited | $74.79 | 2021 | |
| Kci USA, INC. | $73.97 | 2019-2021 | |
| Csl Behring | $67.03 | 2021-2022 | |
| Tela Bio, INC. | $66.10 | 2021-2022 | |
| Medtronic, INC. | $52.38 | 2022-2025 | Venaseal |
| Janssen Pharmaceuticals, INC | $44.13 | 2021-2022 | |
| Kls-Martin L.P. | $43.53 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $42.39 | 2019-2020 | |
| Aroa Biosurgery Incorporated | $31.76 | 2023 | |
| Allergan, INC. | $31.38 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $28.51 | 2021 | |
| Ambu INC. | $24.40 | 2022 | |
| Acacia Pharma INC | $23.41 | 2021 | |
| Pfizer INC. | $23.16 | 2020-2021 | |
| Melinta Therapeutics, LLC | $18.74 | 2019 | |
| Covidien LP | $13.12 | 2020 | |
| Stryker Corporation | $11.16 | 2021 | |
| Medela LLC | $9.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Adye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.